Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition

For decades, stem cell therapies for pulmonary hypertension (PH) have progressed from laboratory hypothesis to clinical practice. Promising preclinical investigations have laid both a theoretical and practical foundation for clinical application of mesenchymal stem cells (MSCs) for PH therapy. Howev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Cell Mol Biol
Main Authors: Huang, Junyi, Lu, Wenju, Ouyang, Haiping, Chen, Yuqin, Zhang, Chenting, Luo, Xiaoyun, Li, Meichan, Shu, Jiaze, Zheng, Qiuyu, Chen, Haixia, Chen, Jiyuan, Tang, Haiyang, Sun, Dejun, Yuan, Jason X.-J., Yang, Kai, Wang, Jian
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6938136/
https://ncbi.nlm.nih.gov/pubmed/31211918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2018-0165OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados